v3.26.3
Stockholders' Equity (Tables)
3 Months Ended
Sep. 30, 2026
Stockholders' Equity  
Schedule of stock-based compensation expense in the consolidated statements of operations

We recorded stock-based compensation expense in the consolidated statements of operations as follows (in thousands):

​

​

​

​

​

​

​

​

​

Three Months Ended September 30, 

​

  ​ ​ ​

2025

  ​ ​ ​

2026

Cost of goods sold

​

$

285

​

$

310

Selling, general and administrative

​

​

5,753

​

​

5,478

Research and development

​

​

161

​

​

173

Stock-based compensation expense

​

$

6,199

​

$

5,961

​

Schedule of stock option activity

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Weighted

​

​

​

​

​

​

​

​

​

Average

​

Weighted-Average

​

Aggregate

​

​

Number of

​

Exercise

​

Remaining Contractual

​

Intrinsic Value

​

  ​ ​ ​

Options

  ​ ​ ​

Price

  ​ ​ ​

Term

  ​ ​ ​

(in thousands)

Outstanding at June 30, 2026

 

51,449

 

$

147.69

 

​

​

​

​

Granted

 

—

​

​

—

​

​

​

​

​

Exercised

 

(831)

​

​

123.39

​

​

​

​

​

Expired or forfeited

 

(197)

​

​

135.94

​

​

​

​

​

Outstanding at September 30, 2026

 

50,421

​

$

148.14

​

7.2 years

​

$

2,932

Exercisable at September 30, 2026

​

25,838

​

$

107.42

 

6.2 years

​

$

2,247

​

Summary of RSU award activity

​

​

​

​

​

​

​

​

​

​

​

Weighted-

​

​

​

​

Average

​

  ​ ​ ​

Shares

  ​ ​ ​

Fair Value

Nonvested at June 30, 2026

 

241,735

​

$

156.11

Granted

 

130,112

​

​

211.23

Vested

 

(184,360)

​

​

168.14

Forfeited

 

(11,389)

​

​

97.43

Nonvested at September 30, 2026

 

176,098

​

$

188.03

​